{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:34:50Z","timestamp":1785803690470,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.berh.2023.101844","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T18:49:25Z","timestamp":1686854965000},"page":"101844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Deficiency of adenosine deaminase 2 (DADA2): Review"],"prefix":"10.1016","volume":"37","author":[{"given":"Vikas","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2023.101844_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2023.101844_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Elkan","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2023.101844_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/art.41500","article-title":"Deficiency of adenosine deaminase 2 (DADA2) in adults and children: experience from India","volume":"73","author":"Sharma","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib5","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1007\/s10067-021-05711-w","article-title":"Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment","volume":"40","author":"Pinto","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01115116","article-title":"Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency","volume":"2","author":"Simmonds","year":"1982","journal-title":"Biosci Rep"},{"key":"10.1016\/j.berh.2023.101844_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1189\/jlb.1109764","article-title":"Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages","volume":"88","author":"Zavialov","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.berh.2023.101844_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","article-title":"Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells","volume":"74","author":"Kaljas","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.berh.2023.101844_bib9","doi-asserted-by":"crossref","first-page":"12367","DOI":"10.1074\/jbc.M109.083527","article-title":"Structural basis for the growth factor activity for human adenosine deaminase ADA2","volume":"285","author":"Zavialov","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.berh.2023.101844_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/BC.2006.042","article-title":"Human plasma adenosine deaminase 2 is secreted by activated monocytes","volume":"387","author":"Iwaki-Egawa","year":"2006","journal-title":"Biol Chem"},{"key":"10.1016\/j.berh.2023.101844_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4046\/trd.2017.80.1.77","article-title":"Mycobacterium tuberculosis ESAT6 and CPF10 induce adenosine deaminase 2 mRNA expression in monocytes-derived macrophages","volume":"80","author":"Bae","year":"2017","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.berh.2023.101844_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1183\/09031936.96.09040747","article-title":"Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy","volume":"9","author":"Valdes","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/j.berh.2023.101844_bib13","first-page":"178","article-title":"Plasma adenosine deaminase 2: a marker for human immunodeficiency virus infection","volume":"4","author":"Niedzwicki","year":"1991","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.berh.2023.101844_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","article-title":"Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations","volume":"55","author":"Van Montfrans","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2023.101844_bib16","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101844_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3899\/jrheum.181384","article-title":"A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2","volume":"47","author":"\u00d6zen","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12969-016-0111-7","article-title":"Monogenic polyarteritis: the lesson of ADA2 deficiency","volume":"14","author":"Caorsi","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.berh.2023.101844_bib19","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)","volume":"145","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib20","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of adenosine de- aminase type 2: a description of phenotype and genotype in fifteen cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1546-0096-12-44","article-title":"Mutations in CECR1 associated with a neutrophil signature in peripheral blood","volume":"12","author":"Belot","year":"2014","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.2018892752","article-title":"Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2","volume":"134","author":"Carmona-Rivera","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.berh.2023.101844_bib23","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.celrep.2013.05.022","article-title":"Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity","volume":"3","author":"Schena","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.berh.2023.101844_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/eji.202048549","article-title":"Dysregulation in B cell responses and T follicular helper cell function in ADA2 deficiency patients","volume":"51","author":"Schena","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2018.00282","article-title":"Vasculopathy, immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2","volume":"6","author":"Lee","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.berh.2023.101844_bib26","doi-asserted-by":"crossref","first-page":"108411","DOI":"10.1016\/j.clim.2020.108411","article-title":"Polyarteritis nodosa and deficiency of adenosine deaminase 2-shared genealogy, generations apart","volume":"215","author":"Huang","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib27","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","article-title":"A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience","volume":"26","author":"Rama","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.berh.2023.101844_bib28","doi-asserted-by":"crossref","first-page":"811473","DOI":"10.3389\/fimmu.2021.811473","article-title":"The spectrum of the deficiency of adenosine deaminase 2: an observational analysis of a 60 patient cohort","volume":"12","author":"Barron","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10875-019-00700-w","article-title":"Unreported missense mutation in the dimerization domain of ADA2 leads to ADA2 deficiency associated with severe oral ulcers and neutropenia in a female Somalian patient\u2014addendum to the genotype-phenotype puzzle","volume":"40","author":"G\u00f6schl","year":"2020","journal-title":"J Clin Immunol"},{"issue":"suppl 10","key":"10.1016\/j.berh.2023.101844_bib30","article-title":"Screening of patients with adult-onset idiopathic polyarteritis nodosa for deficiency of adenosine deaminase 2 [abstract]","volume":"70","author":"Schnappauf","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib31","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.jaad.2020.03.110","article-title":"Clinical and pathological dermatological features of deficiency of adenosine deaminase 2: multicenter retrospective observational study","volume":"83","author":"Chasset","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.berh.2023.101844_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neurad.2018.05.002","article-title":"Deficiency of adenosine deaminase 2; special focus on central nervous system imaging","volume":"46","author":"Bulut","year":"2019","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.berh.2023.101844_bib33","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","article-title":"ADA2 deficiency: clonal lymphoproliferation in a subset of patients","volume":"141","author":"Trotta","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00296-019-04444-z","article-title":"The same mutation in a family with adenosine deaminase 2 deficiency","volume":"41","author":"Sozeri","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2023.101844_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00415-016-8070-y","article-title":"Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis","volume":"263","author":"Poswar Fde","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.berh.2023.101844_bib36","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/WNL.0000000000001581","article-title":"Unexplained early-onset lacunar stroke and inflammatory skin lesions: consider ADA2 deficiency","volume":"84","author":"Westendorp","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.berh.2023.101844_bib37","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3899\/jrheum.150024","article-title":"A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations","volume":"42","author":"Batu","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00296-017-3740-3","article-title":"Clinical, imaging and genotypical features of three deceased and five surviving cases of ADA2 deficiency","volume":"38","author":"Sahin","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2023.101844_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/20469047.2018.1559495","article-title":"A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-\u03b1","volume":"40","author":"Sahin","year":"2020","journal-title":"Paediatr Int Child Health"},{"key":"10.1016\/j.berh.2023.101844_bib40","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/art.40913","article-title":"Identification of novel adenosine deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis","volume":"71","author":"Gibson","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1546-0096-12-44","article-title":"Mutations in CECR1 associated with neutrophil signature in peripheral blood","volume":"12","author":"Belot","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.berh.2023.101844_bib42","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/art.40147","article-title":"Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood","volume":"69","author":"Schepp","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","article-title":"Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency","volume":"135","author":"Van Eyck","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib44","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1097\/RHU.0000000000001384","article-title":"A rare case of adenosine deaminase 2 deficiency presenting with temporal arteritis","volume":"27","author":"Dimachkie","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/art.41549","article-title":"Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2","volume":"73","author":"Schnappauf","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000495794","article-title":"Adenosine deaminase two and immunoglobulin M accurately differentiate adult Sneddon\u2019s syndrome of unknown cause","volume":"46","author":"Santo","year":"2019","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.berh.2023.101844_bib47","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s10875-018-0565-0","article-title":"Warts and DADA2: a mere coincidence?","volume":"38","author":"Arts","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib48","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s10875-020-00812-8","article-title":"Late-onset EBV susceptibility and refractory pure red cell aplasia revealing DADA2","volume":"40","author":"Le Voyer","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib49","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3389\/fimmu.2018.02767","article-title":"ALPS-like phenotype caused by ADA2 deficiency rescued by allogeneic hematopoietic stem cell transplantation","volume":"9","author":"Barzaghi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pbc.26912","article-title":"Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis","volume":"65","author":"Alsultan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.berh.2023.101844_bib51","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMc1405506","article-title":"Mutant ADA2 in vasculopathies","volume":"371","author":"Van Eyck","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.berh.2023.101844_bib52","doi-asserted-by":"crossref","first-page":"754029","DOI":"10.3389\/fimmu.2021.754029","article-title":"Case report: deficiency of adenosine deaminase 2 presenting with overlapping features of autoimmune lymphoproliferative syndrome and bone marrow failure","volume":"12","author":"Dell\u2019Orso","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10875-019-0590-7","article-title":"Childhood Hodgkin\u2019s lymphoma: think DADA2","volume":"39","author":"Alabbas","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib54","doi-asserted-by":"crossref","first-page":"108443","DOI":"10.1016\/j.clim.2020.108443","article-title":"ADA2 deficiency complicated by EBV-driven lymphoproliferative disease","volume":"215","author":"Staples","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib55","first-page":"142","article-title":"Phenotype variability including Behcet\u2019s disease-like manifestations in DADA2 patients due to homozygous c.973-2A>G splice site mutation","volume":"37","author":"van Well","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10875-019-00734-0","article-title":"ADA2 deficiency: case series of five patients with varying phenotypes","volume":"40","author":"Tanatar","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000236","article-title":"ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters","volume":"2","author":"Uettwiller","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2023.101844_bib58","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0948","article-title":"Renal amyloidosis in deficiency of adenosine deaminase 2: successful experience with canakinumab","volume":"142","author":"Kisla Ekinci","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.berh.2023.101844_bib59","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00431-014-2320-8","article-title":"Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy","volume":"173","author":"Garg","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.berh.2023.101844_bib60","doi-asserted-by":"crossref","first-page":"869570","DOI":"10.3389\/fimmu.2022.869570","article-title":"Deficiency of human adenosine deaminase type 2-a diagnostic conundrum for the hematologist","volume":"13","author":"Pilania","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib61","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-2266","article-title":"ADA2 deficiency mimicking idiopathic multicentric castleman disease","volume":"142","author":"Van Nieuwenhove","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.berh.2023.101844_bib62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/03009742.2017.1324912","article-title":"Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency","volume":"47","author":"Nihira","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.berh.2023.101844_bib64","doi-asserted-by":"crossref","first-page":"O40","DOI":"10.1186\/1546-0096-13-S1-O40","article-title":"The deficiency of adenosine deaminase type 2-results of therapeutic intervention","volume":"13","author":"Ombrello","year":"2015","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib66","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment strategies for deficiency of adenosine deaminase 2","volume":"380","author":"Ombrello","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2023.101844_bib67","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3899\/jrheum.180820","article-title":"Thirty years of followup in 3 patients with familial polyarteritis nodosa due to adenosine deaminase 2 deficiency","volume":"46","author":"Leibowitz","year":"2019","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2023.101844_bib68","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","article-title":"Hematopoietic stem cell transplant rescues the hematological, immunological and vascular phenotype in DADA2","volume":"130","author":"Hashem","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.berh.2023.101844_bib69","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10875-018-0487-x","article-title":"Novel mutation in CECR1 leads to deficiency of ADA2 with associated neutropenia","volume":"38","author":"Cipe","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10875-018-0480-4","article-title":"Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure","volume":"38","author":"Michniacki","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib71","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","article-title":"Extending the clinical phenotype of adenosine deaminase 2 deficiency","volume":"177","author":"Ben-Ami","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/j.berh.2023.101844_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1108853","article-title":"Editorial: DADA2 and other monogenic vasculitides","volume":"13","author":"Lee","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib63","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00251-018-01101-w","article-title":"A Chinese DADA2 patient: report of two novel mutations and successful HSCT","volume":"71","author":"Liu","year":"2019","journal-title":"Immunogenetics"},{"key":"10.1016\/j.berh.2023.101844_bib73","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bmt.2017.173","article-title":"Successful reduced intensity hematopoietic cell transplant in a patient with deficiency of adenosine deaminase 2","volume":"52","author":"Hashem","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.berh.2023.101844_bib74","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1097\/MPH.0000000000000805","article-title":"Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2","volume":"39","author":"Hashem","year":"2017","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.berh.2023.101844_bib75","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1093\/rheumatology\/keaa837","article-title":"Anti-tumour necrosis factor treatment for the prevention of ischemic events in patients with adenosine deaminase 2 (DADA2)","volume":"60","author":"Cooray","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2023.101844_bib76","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic cell transplantation cures adenosine deaminase deficiency: report on 30 patients","volume":"41","author":"Hashem","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932385","article-title":"Allogenic hematopoietic cell transplantation for patients with deficiency of adenosine deaminase 2 (DADA2): approaches, obstacles and special considerations","volume":"13","author":"Hashem","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2023.101844_bib78","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1182\/bloodadvances.2020003811","article-title":"Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency","volume":"5","author":"Zoccolillo","year":"2021","journal-title":"Blood Adv"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422300030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422300030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:22:33Z","timestamp":1761499353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169422300030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S152169422300030X"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2023.101844","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of adenosine deaminase 2 (DADA2): Review","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2023.101844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101844"}}